XS-002

N/A

Report date: 2023/02/22 14:10:25

Base Information

Drug NameXS-002
Drug Alias NameXS-002XS_002XS-002（人多能干细胞来源的特定神经细胞类型）
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A